BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34916520)

  • 1. Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda.
    Nalwoga A; Roshan R; Moore K; Marshall V; Miley W; Labo N; Nakibuule M; Cose S; Rochford R; Newton R; Whitby D
    Nat Commun; 2021 Dec; 12(1):7323. PubMed ID: 34916520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chimpanzee rhadinovirus sequence related to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8: increased detection after HIV-1 infection in the absence of disease.
    Greensill J; Sheldon JA; Murthy KK; Bessonette JS; Beer BE; Schulz TF
    AIDS; 2000 Dec; 14(17):F129-35. PubMed ID: 11125908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy.
    Labo N; Miley W; Benson CA; Campbell TB; Whitby D
    AIDS; 2015 Jun; 29(10):1217-25. PubMed ID: 26035321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal analysis of the humoral response to Kaposi's sarcoma-associated herpesvirus after primary infection in children.
    Olp LN; Minhas V; Gondwe C; Poppe LK; Rogers AM; Kankasa C; West JT; Wood C
    J Med Virol; 2016 Nov; 88(11):1973-81. PubMed ID: 27062052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily.
    Amodio E; Goedert JJ; Barozzi P; Riva G; Firenze A; Bonura F; Viviano E; Romano N; Luppi M
    Cancer Sci; 2011 Oct; 102(10):1769-73. PubMed ID: 21740480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
    Simpson GR; Schulz TF; Whitby D; Cook PM; Boshoff C; Rainbow L; Howard MR; Gao SJ; Bohenzky RA; Simmonds P; Lee C; de Ruiter A; Hatzakis A; Tedder RS; Weller IV; Weiss RA; Moore PS
    Lancet; 1996 Oct; 348(9035):1133-8. PubMed ID: 8888167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposi Sarcoma-Associated Herpesvirus in a Rural Ugandan Cohort, 1992-2008.
    Newton R; Labo N; Wakeham K; Miley W; Asiki G; Johnston WT; Whitby D
    J Infect Dis; 2018 Jan; 217(2):263-269. PubMed ID: 29099933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's sarcoma-associated herpesvirus seropositivity is associated with parasite infections in Ugandan fishing communities on Lake Victoria islands.
    Nalwoga A; Webb EL; Chihota B; Miley W; Walusimbi B; Nassuuna J; Sanya RE; Nkurunungi G; Labo N; Elliott AM; Cose S; Whitby D; Newton R
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007776. PubMed ID: 31618208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.
    Newton R; Carpenter L; Casabonne D; Beral V; Babiker A; Darbyshire J; Weller I; Weiss R; Kwan A; Bourboulia D; Munoz F; Lagos D; Boshoff C
    Br J Cancer; 2006 May; 94(10):1504-9. PubMed ID: 16705315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda.
    Ziegler J; Newton R; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Reeves G; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C;
    Int J Cancer; 2003 Jan; 103(2):233-40. PubMed ID: 12455038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD8 and CD4 T-cell response against Kaposi's sarcoma-associated herpesvirus is skewed towards early and late lytic antigens.
    Robey RC; Lagos D; Gratrix F; Henderson S; Matthews NC; Vart RJ; Bower M; Boshoff C; Gotch FM
    PLoS One; 2009 Jun; 4(6):e5890. PubMed ID: 19536280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents.
    Mayama S; Cuevas LE; Sheldon J; Omar OH; Smith DH; Okong P; Silvel B; Hart CA; Schulz TF
    Int J Cancer; 1998 Sep; 77(6):817-20. PubMed ID: 9714046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, China.
    Fu B; Sun F; Li B; Yang L; Zeng Y; Sun X; Xu F; Rayner S; Guadalupe M; Gao SJ; Wang L
    J Med Virol; 2009 Aug; 81(8):1422-31. PubMed ID: 19551832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group.
    Chang Y; Ziegler J; Wabinga H; Katangole-Mbidde E; Boshoff C; Schulz T; Whitby D; Maddalena D; Jaffe HW; Weiss RA; Moore PS
    Arch Intern Med; 1996 Jan; 156(2):202-4. PubMed ID: 8546554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide.
    Davis DA; Humphrey RW; Newcomb FM; O'Brien TR; Goedert JJ; Straus SE; Yarchoan R
    J Infect Dis; 1997 May; 175(5):1071-9. PubMed ID: 9129068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome.
    Labo N; Miley W; Marshall V; Gillette W; Esposito D; Bess M; Turano A; Uldrick T; Polizzotto MN; Wyvill KM; Bagni R; Yarchoan R; Whitby D
    PLoS Pathog; 2014 Mar; 10(3):e1004046. PubMed ID: 24675986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex-vivo recognition of late-lytic CD8 epitopes specific for Kaposi's sarcoma-associated herpesvirus (KSHV) by HIV/KSHV-coinfected individuals.
    Robey RC; Mletzko S; Bower M; Meys R; Boffito M; Nelson M; Bunker CB; Gotch FM
    Viral Immunol; 2011 Jun; 24(3):211-20. PubMed ID: 21668362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ cytokines in HIV/HHV-8 coinfection.
    Silva DMD; Gonçales JP; Silva Júnior JVJ; Lopes TRR; Bezerra LA; Barros de Lorena VM; Duarte Coêlho MRC
    J Med Virol; 2021 Jun; 93(6):4033-4037. PubMed ID: 32926412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutual detection of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in blood and saliva of Cameroonians with and without Kaposi's sarcoma.
    Labo N; Marshall V; Miley W; Davis E; McCann B; Stolka KB; Ndom P; Hemingway-Foday JJ; Abassora M; Newton R; Smith JS; Whitby D
    Int J Cancer; 2019 Nov; 145(9):2468-2477. PubMed ID: 31265124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.